Recent Updates
Recently added Catalysts
STAA Positive Sentiment

STAAR Surgical to Participate in Upcoming Investor Conferences

Tuesday, October 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: STAAR Surgical announced its participation in two upcoming investor conferences in November 2026. CEO Warren Foust and CFO Deborah Andrews will represent the company at these events. The conferences will provide an opportunity to discuss the company's advancements in phakic IOLs and the EVO family of lenses.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in two major investor conferences.
  • Leadership presence with CEO and CFO attending.
  • Focus on innovative vision correction technology.

Full Press Release Details

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that Warren Foust, President and Chief Executive Officer, and Deborah Andrews, Executive Vice President and Chief Financial Officer, will participate in two investor conferences in November: Stifel 2026 Healthcare Conference Date: Tuesday, November 10, 2026 Location: New York, NY Fires

Frequently Asked Questions

Who will represent STAAR Surgical at the conferences?

CEO Warren Foust and CFO Deborah Andrews will represent the company.

When will STAAR Surgical participate in the conferences?

STAAR Surgical will participate in conferences on November 10, 2026.

What is the focus of STAAR Surgical's technology?

The focus is on phakic IOLs and the EVO family of lenses.

Where will the investor conferences take place?

The conferences will be held in New York, NY.

ShareAdd on Google
Tags: STAA STAAR Surgical Warren Foust Deborah Andrews EVO ICL investor conferences
Last updated: Oct 27, 2026

Biotech snapshot

Cash runway
$181M liquidity · $0M/mo burn
Low dilution risk